Overview

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Status:
Completed
Trial end date:
2018-03-21
Target enrollment:
Participant gender:
Summary
To evaluate the impact of a selective androgen receptor modulator combined with an aromatase inhibitor in reducing high mammographic breast density.
Phase:
Phase 1
Details
Lead Sponsor:
Havah Therapeutics Pty Ltd
Collaborator:
GTx
Treatments:
Anastrozole